Gillette India Ltd (GILLETTE)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 10305.00
% Change: 0.00% (Prev Close: 10305.00)

Volume: 9,165
% Change: 6.24% (Prev Volume: 8,627)

Delivery: 4,130
Delivery % : 45.06
% Change: 13.81% (Prev Delivery: 3,629)

Turnover: 941 Lacs
% Change: 5.49% (Prev Turnover: 892)

💹 EOD Valuation

P/E Ratio: 59.60
P/B Ratio: 32.82
Market Cap: 33594 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: GILLETTE
Market Cap: 32900 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 11505.00
52 Week Low: 7411.65

All-Time High: 11505.00 Rs.
All-Time Low: 520.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.52% | 3.27% | 28.83% | 12.51% | 23.50%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 75.00%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 4.82%

Change (3Y | 1Y): 2.64% | 0.49%

DII Holding

DII Holding: 9.60%

Change (3Y | 1Y): -0.83% | -0.29%

Public Holding: 10.58%

🏦 Financial Strength

Debt to Equity: 0.00
Debt: 0.05 Rs. Cr.

Book Value: 313.98 Rs.
Current Ratio: 1.64
Interest Coverage: 79.49
Free Cash Flow: 284.33 Rs. Cr.

📈 Growth & Sales

Sales Growth: 11.72%

Sales Growth Qtr (YOY | QoQ):
9.51% | -7.92%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
3.72% | 4.09% | 11.72%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 36.84%

Profit Growth Qtr (YOY | QoQ):
25.63% | -8.19%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
10.45% | 10.56% | 36.84%

EPS Rs.

EPS (TTM): 172.89 Rs.

EPS Qtr (Last Year | Latest):
35.59 Rs. | 44.71 Rs.

EPS Annual (Last Annual | Annual March):
109.15 Rs. | 128.17 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
10.45% | 10.56%

Net Profit Rs. Cr.

Net Profit (TTM): 563.35 Rs. Cr.

Net Profit (Annual - March): 417.66 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
115.97| 158.68 | 145.69

EBITDA Rs. Cr.

EBITDA (Quarter): 216.93 Rs. Cr.
EBITDA (Previous Yr Ql): 180.10 Rs. Cr.

EBITDA (Annual - March): 628.30 Rs. Cr.
EBITDA (Previous Annual): 561.88 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
9.58% | 8.53%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 27.51%

OPM Qtr (Previous | Current):
29.42% | 29.75%

OPM Annual (5 Yrs | Last Yr | March):
22.98% | 21.79% | 26.86%

Return on Equity %

ROE: 41.62%

ROE (5 Yrs | 3 Yrs | Last Yr):
36.06% | 38.62% | 38.49%

Return on Capital Employed %

ROCE: 56.06%

ROCE (5 Yrs | 3 Yrs | Last Yr):
49.64% | 53.08% | 52.01%

Return on Assets %

ROA (TTM): 21.84%

ROA (5 Yrs | 3 Yrs | Last Yr):
20.35% | 20.40% | 20.14%

PEG Ratio: 5.53
Dividend Yield: 1.11%

PE 3 Yrs: 57.13
PE 5 Yrs: 59.19

Dividend Yield: 1.11%

👥 Company

Gillette India Ltd

GILLETTE

Promoter Holding: %

Gland Pharma Ltd (GLAND)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 1914.80
% Change: 2.40% (Prev Close: 1870.00)

Volume: 4,31,248
% Change: 444.84% (Prev Volume: 79,151)

Delivery: 3,67,978
Delivery % : 85.33
% Change: 642.61% (Prev Delivery: 49,552)

Turnover: 8,232 Lacs
% Change: 454.14% (Prev Turnover: 1,486)

💹 EOD Valuation

P/E Ratio: 40.96
P/B Ratio: 3.45
Market Cap: 31556 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: GLAND
Market Cap: 30834 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 2131.00
52 Week Low: 1200.00

All-Time High: 4350.00 Rs.
All-Time Low: 861.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-4.47% | 14.30% | 14.33% | -0.54% | -8.78%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 51.83%

Change (3Y | 1Y): -6.04% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 7.39%

Change (3Y | 1Y): -2.02% | 0.49%

DII Holding

DII Holding: 32.86%

Change (3Y | 1Y): 15.50% | -0.41%

Public Holding: 7.93%

🏦 Financial Strength

Debt to Equity: 0.03
Debt: 313.73 Rs. Cr.

Book Value: 555.41 Rs.
Current Ratio: 4.33
Interest Coverage: 25.17
Free Cash Flow: 520.90 Rs. Cr.

📈 Growth & Sales

Sales Growth: -2.34%

Sales Growth Qtr (YOY | QoQ):
7.41% | 5.66%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
16.36% | 8.47% | -2.34%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 6.66%

Profit Growth Qtr (YOY | QoQ):
49.89% | 15.51%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-1.69% | -16.73% | 6.66%

EPS Rs.

EPS (TTM): 46.75 Rs.

EPS Qtr (Last Year | Latest):
8.73 Rs. | 13.08 Rs.

EPS Annual (Last Annual | Annual March):
46.90 Rs. | 42.40 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-2.89% | -16.81%

Net Profit Rs. Cr.

Net Profit (TTM): 770.24 Rs. Cr.

Net Profit (Annual - March): 698.53 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
143.76| 186.54 | 215.48

EBITDA Rs. Cr.

EBITDA (Quarter): 425.29 Rs. Cr.
EBITDA (Previous Yr Ql): 315.83 Rs. Cr.

EBITDA (Annual - March): 1481.33 Rs. Cr.
EBITDA (Previous Annual): 1502.71 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
6.58% | -5.04%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 23.99%

OPM Qtr (Previous | Current):
24.39% | 24.43%

OPM Annual (5 Yrs | Last Yr | March):
28.28% | 23.53% | 22.59%

Return on Equity %

ROE: 7.81%

ROE (5 Yrs | 3 Yrs | Last Yr):
12.44% | 9.22% | 9.26%

Return on Capital Employed %

ROCE: 11.89%

ROCE (5 Yrs | 3 Yrs | Last Yr):
18.60% | 13.41% | 13.58%

Return on Assets %

ROA (TTM): 6.41%

ROA (5 Yrs | 3 Yrs | Last Yr):
11.99% | 8.08% | 7.96%

PEG Ratio: -2.39
Dividend Yield: 0.96%

PE 3 Yrs: 37.11
PE 5 Yrs: 39.99

Dividend Yield: 0.96%

👥 Company

Gland Pharma Ltd

GLAND

Promoter Holding: %

Glaxosmithkline Pharmaceuticals Ltd (GLAXO)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 2820.00
% Change: 0.64% (Prev Close: 2802.20)

Volume: 55,776
% Change: -19.53% (Prev Volume: 69,313)

Delivery: 36,144
Delivery % : 64.80
% Change: -8.98% (Prev Delivery: 39,711)

Turnover: 1,566 Lacs
% Change: -19.32% (Prev Turnover: 1,940)

💹 EOD Valuation

P/E Ratio: 50.28
P/B Ratio: 24.48
Market Cap: 47771 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: GLAXO
Market Cap: 47180 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 3515.95
52 Week Low: 1921.00

All-Time High: 3515.95 Rs.
All-Time Low: 346.05 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-1.83% | -19.24% | 0.92% | -2.53% | 24.47%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 75.00%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 4.89%

Change (3Y | 1Y): 2.73% | 0.37%

DII Holding

DII Holding: 7.71%

Change (3Y | 1Y): -2.94% | -0.08%

Public Holding: 12.41%

🏦 Financial Strength

Debt to Equity: 0.01
Debt: 9.95 Rs. Cr.

Book Value: 115.19 Rs.
Current Ratio: 1.20
Interest Coverage: 945.68
Free Cash Flow: 1272.60 Rs. Cr.

📈 Growth & Sales

Sales Growth: 6.65%

Sales Growth Qtr (YOY | QoQ):
-1.16% | -17.37%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
3.06% | 4.58% | 6.65%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 22.94%

Profit Growth Qtr (YOY | QoQ):
12.44% | -22.01%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
34.71% | -19.63% | 22.94%

EPS Rs.

EPS (TTM): 56.09 Rs.

EPS Qtr (Last Year | Latest):
10.76 Rs. | 12.10 Rs.

EPS Annual (Last Annual | Annual March):
34.83 Rs. | 54.75 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
34.71% | -19.63%

Net Profit Rs. Cr.

Net Profit (TTM): 950.26 Rs. Cr.

Net Profit (Annual - March): 927.58 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
182.33| 262.87 | 205.01

EBITDA Rs. Cr.

EBITDA (Quarter): 294.92 Rs. Cr.
EBITDA (Previous Yr Ql): 266.18 Rs. Cr.

EBITDA (Annual - March): 1255.15 Rs. Cr.
EBITDA (Previous Annual): 981.62 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
11.33% | 14.47%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 32.03%

OPM Qtr (Previous | Current):
34.20% | 31.20%

OPM Annual (5 Yrs | Last Yr | March):
25.52% | 26.31% | 31.44%

Return on Equity %

ROE: 46.87%

ROE (5 Yrs | 3 Yrs | Last Yr):
44.83% | 36.39% | 37.32%

Return on Capital Employed %

ROCE: 63.25%

ROCE (5 Yrs | 3 Yrs | Last Yr):
45.09% | 50.33% | 51.33%

Return on Assets %

ROA (TTM): 22.80%

ROA (5 Yrs | 3 Yrs | Last Yr):
23.08% | 18.90% | 19.08%

PEG Ratio: -2.54
Dividend Yield: 1.51%

PE 3 Yrs: 53.00
PE 5 Yrs: 56.12

Dividend Yield: 1.51%

👥 Company

Glaxosmithkline Pharmaceuticals Ltd

GLAXO

Promoter Holding: %

Glenmark Pharmaceuticals Ltd (GLENMARK)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 2115.70
% Change: 2.92% (Prev Close: 2055.70)

Volume: 12,69,358
% Change: 50.60% (Prev Volume: 8,42,874)

Delivery: 4,77,073
Delivery % : 37.58
% Change: 22.33% (Prev Delivery: 3,89,989)

Turnover: 26,679 Lacs
% Change: 53.89% (Prev Turnover: 17,336)

💹 EOD Valuation

P/E Ratio: 79.21
P/B Ratio: 6.75
Market Cap: 59705 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: GLENMARK
Market Cap: 54293 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 2286.15
52 Week Low: 1274.70

All-Time High: 2286.15 Rs.
All-Time Low: 109.25 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-2.35% | 26.05% | 42.72% | 18.85% | 75.40%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 46.65%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 20.62%

Change (3Y | 1Y): -3.61% | -2.53%

DII Holding

DII Holding: 17.64%

Change (3Y | 1Y): 7.14% | 3.04%

Public Holding: 15.05%

🏦 Financial Strength

Debt to Equity: 0.28
Debt: 2472.67 Rs. Cr.

Book Value: 313.60 Rs.
Current Ratio: 1.56
Interest Coverage: 8.66
Free Cash Flow: -1574.75 Rs. Cr.

📈 Growth & Sales

Sales Growth: 10.99%

Sales Growth Qtr (YOY | QoQ):
0.62% | 0.25%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
4.60% | 2.68% | 10.99%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 158.73%

Profit Growth Qtr (YOY | QoQ):
-23.49% | 972.37%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
11.77% | 6.25% | 158.73%

EPS Rs.

EPS (TTM): 26.71 Rs.

EPS Qtr (Last Year | Latest):
12.06 Rs. | 1.66 Rs.

EPS Annual (Last Annual | Annual March):
-53.22 Rs. | 37.11 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
11.77% | 6.24%

Net Profit Rs. Cr.

Net Profit (TTM): 753.86 Rs. Cr.

Net Profit (Annual - March): 1047.15 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
340.24| 4.38 | 46.97

EBITDA Rs. Cr.

EBITDA (Quarter): 606.96 Rs. Cr.
EBITDA (Previous Yr Ql): 619.70 Rs. Cr.

EBITDA (Annual - March): 2465.11 Rs. Cr.
EBITDA (Previous Annual): 2033.80 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
5.81% | -0.38%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 17.57%

OPM Qtr (Previous | Current):
17.23% | 17.78%

OPM Annual (5 Yrs | Last Yr | March):
16.00% | 10.12% | 17.65%

Return on Equity %

ROE: 15.79%

ROE (5 Yrs | 3 Yrs | Last Yr):
-1.40% | -9.94% | -51.65%

Return on Capital Employed %

ROCE: 19.40%

ROCE (5 Yrs | 3 Yrs | Last Yr):
14.38% | 13.81% | 12.34%

Return on Assets %

ROA (TTM): 8.67%

ROA (5 Yrs | 3 Yrs | Last Yr):
-0.07% | -4.56% | -26.12%

PEG Ratio: 6.52
Dividend Yield: 0.13%

PE 3 Yrs: 27.73
PE 5 Yrs: 15.57

Dividend Yield: 0.13%

👥 Company

Glenmark Pharmaceuticals Ltd

GLENMARK

Promoter Holding: %

Global Health Ltd (MEDANTA)

📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 1378.00
% Change: -0.43% (Prev Close: 1384.00)

Volume: 2,00,830
% Change: -13.05% (Prev Volume: 2,30,979)

Delivery: 1,29,324
Delivery % : 64.39
% Change: -0.41% (Prev Delivery: 1,29,856)

Turnover: 2,768 Lacs
% Change: -13.89% (Prev Turnover: 3,215)

💹 EOD Valuation

P/E Ratio: 69.32
P/B Ratio: 10.93
Market Cap: 37041 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: MEDANTA
Market Cap: 36929 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 1456.50
52 Week Low: 935.50

All-Time High: 1513.90 Rs.
All-Time Low: 390.55 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
7.57% | 17.36% | 16.39% | 23.69% | 0.00%

👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 33.01%

Change (3Y | 1Y): 0.00% | -0.02%

Pledged %: 0.00%

FII Holding

FII Holding: 11.54%

Change (3Y | 1Y): 0.00% | -0.22%

DII Holding

DII Holding: 12.20%

Change (3Y | 1Y): 0.00% | 0.27%

Public Holding: 43.19%

🏦 Financial Strength

Debt to Equity: 0.21
Debt: 717.73 Rs. Cr.

Book Value: 126.08 Rs.
Current Ratio: 2.48
Interest Coverage: 13.47
Free Cash Flow: 110.20 Rs. Cr.

📈 Growth & Sales

Sales Growth: 15.28%

Sales Growth Qtr (YOY | QoQ):
19.71% | 10.69%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
19.73% | 19.43% | 15.28%

💰 Profit & Earnings

Profit Growth %

Profit Growth: 18.20%

Profit Growth Qtr (YOY | QoQ):
49.60% | 56.82%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
70.15% | 38.30% | 18.20%

EPS Rs.

EPS (TTM): 19.88 Rs.

EPS Qtr (Last Year | Latest):
3.96 Rs. | 5.92 Rs.

EPS Annual (Last Annual | Annual March):
17.81 Rs. | 17.92 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
21.25% | 35.61%

Net Profit Rs. Cr.

Net Profit (TTM): 534.03 Rs. Cr.

Net Profit (Annual - March): 481.32 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
106.27| 101.38 | 158.98

EBITDA Rs. Cr.

EBITDA (Quarter): 267.04 Rs. Cr.
EBITDA (Previous Yr Ql): 208.25 Rs. Cr.

EBITDA (Annual - March): 965.04 Rs. Cr.
EBITDA (Previous Annual): 882.79 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
32.58% | 24.82%

📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 24.27%

OPM Qtr (Previous | Current):
24.13% | 23.92%

OPM Annual (5 Yrs | Last Yr | March):
22.47% | 24.70% | 24.00%

Return on Equity %

ROE: 16.48%

ROE (5 Yrs | 3 Yrs | Last Yr):
14.46% | 16.88% | 17.91%

Return on Capital Employed %

ROCE: 19.74%

ROCE (5 Yrs | 3 Yrs | Last Yr):
15.10% | 18.80% | 19.57%

Return on Assets %

ROA (TTM): 11.46%

ROA (5 Yrs | 3 Yrs | Last Yr):
7.93% | 10.63% | 11.40%

PEG Ratio: 1.69
Dividend Yield: 0.04%

PE 3 Yrs: 62.06
PE 5 Yrs: 62.06

Dividend Yield: 0.04%

👥 Company

Global Health Ltd

MEDANTA

Promoter Holding: %